IBB iShares Biotechnology ETF
215.23
-1.17 (-0.54%)
Cotação em Aug 26, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Fechamento Anterior | 216.40 | Intervalo Diário | 214.04 – 216.07 |
| Faixa de 52 Semanas | 137.64 – 217.12 | Volume | 1.39M |
| Volume Médio | 1.55M | AUM | $10.84B (Aug 27, 2026) |
| Taxa de Administração | 0.44% | Yield (TTM) | 0.19% |
| NAV | 216.37 | Prêmio/Desconto | -0.53% indicativo |
| Início | Feb 05, 2001 | Posições | 247 |
| Emissor | iShares | Bolsa | NASDAQ |
| Categoria | Biotech | Índice Acompanhado | Não informado nos dados de origem |
| CUSIP | 464287556 | ISIN | US4642875565 |
| Gestão | Não informado nos dados de origem | ||
Sobre este ETF
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
Descrição fornecida pelo fornecedor de dados do fundo · perfil em Aug 27, 2026.
Gráfico de Preço
Preços de fecho diários (retorno de preço, não retorno total). As linhas de comparação são normalizadas para variação percentual desde o início do período. Fonte: Financial Modeling Prep.
Desempenho
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Início* | |
|---|---|---|---|---|---|---|---|---|---|
| Retorno de preço | +14.28% | +26.70% | +22.78% | +27.53% | +55.43% | +19.02% | +4.61% | +8.52% | +7.43% |
| Retorno total | +14.28% | +26.71% | +22.88% | +27.63% | +55.83% | +19.35% | +4.89% | +8.80% | +7.62% |
* Anualizado. O retorno total usa a série de preços ajustada por dividendos (distribuições reinvestidas); o retorno de preço usa fechamentos não ajustados. Desempenho até Aug 26, 2026. Desempenho passado não garante resultados futuros.
Taxas
| Taxa de administração líquida | 0.44% | Custo anual de um investimento de $10.000 | $44.00 |
Cálculo meramente ilustrativo: expense ratio × 10.000 $. Não inclui custos de negociação, spreads bid/ask, impostos nem variações no valor do investimento. Os detalhes de expense ratio bruto vs. líquido e eventuais isenções de taxa constam do prospeto.
Posições
Posições em Aug 26, 2026 — data de reporte da carteira fornecida pelo provedor de dados; as posições não são em tempo real. 250 linhas na base de dados.
| # | Posição | Ticker | Peso | Ações | Valor de Mercado |
|---|---|---|---|---|---|
| 1 | AMGEN INC | AMGN | 8.42% | 2.07M | $914.8M |
| 2 | VERTEX PHARMACEUTICALS | VRTX | 7.92% | 1.56M | $860.6M |
| 3 | GILEAD SCIENCES | GILD | 7.10% | 5.18M | $771.0M |
| 4 | REGENERON PHARMACEUTICALS | REGN | 5.78% | 752.98K | $627.7M |
| 5 | MODERNA INC | MRNA | 3.96% | 2.71M | $430.6M |
| 6 | ARGENX SE ADR | ARGX | 3.64% | 387.70K | $395.3M |
| 7 | NATERA | NTRA | 3.16% | 1.02M | $343.1M |
| 8 | REVOLUTION MEDICINES | RVMD | 2.76% | 1.42M | $300.3M |
| 9 | ILLUMINA INC | ILMN | 2.33% | 1.13M | $253.4M |
| 10 | BIOGEN | BIIB | 2.22% | 1.09M | $241.1M |
| 11 | ALNYLAM PHARMACEUTICALS | ALNY | 2.19% | 992.13K | $238.2M |
| 12 | BEONE MEDICINES AG | ONC | 2.06% | 594.11K | $223.6M |
| 13 | INSMED | INSM | 1.83% | 1.60M | $198.5M |
| 14 | INCYTE CORP | INCY | 1.76% | 1.48M | $191.6M |
| 15 | UNITED THERAPEUTICS | UTHR | 1.46% | 306.23K | $158.8M |
| 16 | ROIVANT SCIENCES LTD | ROIV | 1.29% | 3.85M | $140.5M |
| 17 | GENMAB SPONSORED ADR | GMAB | 1.23% | 3.90M | $133.9M |
| 18 | ASCENDIS PHARMA | ASND | 1.07% | 461.39K | $116.7M |
| 19 | NEUROCRINE BIOSCIENCES | NBIX | 1.04% | 737.18K | $113.1M |
| 20 | CHARLES RIVER LABORATORIES INTERNA | CRL | 0.97% | 355.15K | $105.7M |
| 21 | MEDPACE HOLDINGS | MEDP | 0.97% | 171.68K | $105.4M |
| 22 | EXELIXIS INC | EXEL | 0.95% | 1.82M | $103.1M |
| 23 | BRIDGEBIO PHARMA | BBIO | 0.93% | 1.26M | $101.4M |
| 24 | HALOZYME THERAPEUTICS | HALO | 0.88% | 876.00K | $95.8M |
| 25 | BIOMARIN PHARMACEUTICAL | BMRN | 0.86% | 1.42M | $93.9M |
| 26 | ARROWHEAD PHARMACEUTICALS | ARWR | 0.81% | 987.41K | $87.8M |
| 27 | BIO TECHNE | TECH | 0.78% | 1.16M | $84.2M |
| 28 | MADRIGAL PHARMACEUTICALS | MDGL | 0.76% | 161.88K | $82.9M |
| 29 | BIONTECH SE ADR | BNTX | 0.72% | 682.37K | $77.8M |
| 30 | IONIS PHARMACEUTICALS | IONS | 0.71% | 1.21M | $76.9M |
| 31 | REPLIGEN | RGEN | 0.67% | 398.07K | $72.3M |
| 32 | PRAXIS PRECISION MEDICINES | PRAX | 0.66% | 194.78K | $71.7M |
| 33 | CYTOKINETICS | CYTK | 0.63% | 889.17K | $68.9M |
| 34 | PROTAGONIST THERAPEUTICS | PTGX | 0.63% | 455.21K | $68.5M |
| 35 | KRYSTAL BIOTECH | KRYS | 0.63% | 191.95K | $68.4M |
| 36 | TWIST BIOSCIENCE | TWST | 0.62% | 444.24K | $67.3M |
| 37 | KYMERA THERAPEUTICS | KYMR | 0.62% | 530.65K | $67.2M |
| 38 | AXSOME THERAPEUTICS | AXSM | 0.61% | 321.33K | $66.0M |
| 39 | VAXCYTE | PCVX | 0.59% | 1.05M | $64.3M |
| 40 | CRINETICS PHARMACEUTICALS | CRNX | 0.57% | 729.96K | $61.9M |
| 41 | SPYRE THERAPEUTICS INC | SYRE | 0.57% | 576.57K | $61.9M |
| 42 | ALKERMES | ALKS | 0.55% | 1.22M | $59.8M |
| 43 | APOGEE THERAPEUTICS | APGE | 0.53% | 424.94K | $57.3M |
| 44 | ABIVAX AMERICAN DEPOSITARY SHARES | ABVX | 0.53% | 483.81K | $57.1M |
| 45 | RHYTHM PHARMACEUTICALS | RYTM | 0.52% | 495.02K | $56.1M |
| 46 | 10X GENOMICS CLASS A | TXG | 0.50% | 840.94K | $54.4M |
| 47 | TEMPUS AI CLASS A | TEM | 0.50% | 789.42K | $54.3M |
| 48 | BRUKER | BRKR | 0.43% | 828.95K | $47.1M |
| 49 | TRAVERE THERAPEUTICS | TVTX | 0.42% | 673.52K | $45.1M |
| 50 | PTC THERAPEUTICS | PTCT | 0.40% | 597.54K | $43.9M |
| 51 | DEFINIUM THERAPEUTICS INC | DFTX | 0.39% | 950.13K | $42.6M |
| 52 | SCHOLAR ROCK HOLDING | SRRK | 0.39% | 718.34K | $41.8M |
| 53 | XENON PHARMACEUTICALS | XENE | 0.38% | 676.46K | $40.9M |
| 54 | CRISPR THERAPEUTICS AG | CRSP | 0.38% | 669.21K | $40.8M |
| 55 | COGENT BIOSCIENCES | COGT | 0.37% | 1.10M | $40.4M |
| 56 | ORUKA THERAPEUTICS INC | ORKA | 0.35% | 378.31K | $38.5M |
| 57 | ACADIA PHARMACEUTICALS | ACAD | 0.35% | 1.26M | $38.5M |
| 58 | MIRUM PHARMACEUTICALS | MIRM | 0.33% | 369.73K | $36.3M |
| 59 | CG ONCOLOGY | CGON | 0.31% | 429.56K | $33.9M |
| 60 | ADAPTIVE BIOTECHNOLOGIES | ADPT | 0.28% | 1.15M | $30.3M |
| 61 | DYNE THERAPEUTICS | DYN | 0.27% | 1.12M | $29.4M |
| 62 | DENALI THERAPEUTICS | DNLI | 0.26% | 1.11M | $27.7M |
| 63 | ERASCA | ERAS | 0.25% | 1.55M | $27.6M |
| 64 | IDEAYA BIOSCIENCES | IDYA | 0.24% | 620.93K | $26.4M |
| 65 | IMMUNOVANT | IMVT | 0.24% | 605.00K | $26.3M |
| 66 | EDGEWISE THERAPEUTICS | EWTX | 0.24% | 586.49K | $25.9M |
| 67 | AMYLYX PHARMACEUTICALS | AMLX | 0.24% | 691.55K | $25.9M |
| 68 | CARIS LIFE SCIENCES | CAI | 0.24% | 912.41K | $25.6M |
| 69 | VERACYTE | VCYT | 0.23% | 579.16K | $25.5M |
| 70 | ENLIVEN THERAPEUTICS | ELVN | 0.23% | 414.48K | $25.3M |
| 71 | RELAY THERAPEUTICS | RLAY | 0.23% | 1.22M | $25.2M |
| 72 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.23% | 2.90M | $24.5M |
| 73 | GRAIL INC | GRAL | 0.23% | 296.36K | $24.5M |
| 74 | LEGEND BIOTECH ADR REP | LEGN | 0.22% | 1.10M | $23.5M |
| 75 | IMMUNITYBIO INC | IBRX | 0.21% | 2.81M | $23.0M |
| 76 | TANGO THERAPEUTICS | TNGX | 0.20% | 891.70K | $22.1M |
| 77 | ABCELLERA BIOLOGICS | ABCL | 0.20% | 1.75M | $21.9M |
| 78 | STRUCTURE THERAPEUTICS ADR | GPCR | 0.20% | 437.09K | $21.8M |
| 79 | BEAM THERAPEUTICS | BEAM | 0.20% | 701.13K | $21.8M |
| 80 | UNIQURE | 0EE0.L | 0.20% | 422.80K | $21.6M |
| 81 | TARSUS PHARMACEUTICALS | TARS | 0.20% | 300.45K | $21.5M |
| 82 | ARCUTIS BIOTHERAPEUTICS | ARQT | 0.19% | 825.29K | $20.5M |
| 83 | NURIX THERAPEUTICS INC | NRIX | 0.18% | 730.17K | $19.7M |
| 84 | ARCUS BIOSCIENCES | RCUS | 0.18% | 623.17K | $19.7M |
| 85 | ULTRAGENYX PHARMACEUTICAL | RARE | 0.16% | 670.38K | $17.7M |
| 86 | CAREDX | CDNA | 0.16% | 348.49K | $17.7M |
| 87 | ZAI LABORATORY ADR REPRESENTING LT | ZLAB | 0.16% | 670.08K | $17.5M |
| 88 | KODIAK SCIENCES | KOD | 0.16% | 431.09K | $17.0M |
| 89 | DISC MEDICINE | IRON | 0.16% | 206.05K | $17.0M |
| 90 | NEWAMSTERDAM PHARMA | NAMS | 0.15% | 599.54K | $16.4M |
| 91 | ATAIBECKLEY INC | ATAI | 0.15% | 2.20M | $16.3M |
| 92 | ADMA BIOLOGICS | ADMA | 0.15% | 1.68M | $16.3M |
| 93 | VERICEL | VCEL | 0.15% | 375.95K | $16.2M |
| 94 | BIOCRYST PHARMACEUTICALS | BCRX | 0.15% | 1.61M | $15.8M |
| 95 | VERA THERAPEUTICS CLASS A | VERA | 0.14% | 434.83K | $15.3M |
| 96 | XENCOR | XNCR | 0.14% | 519.51K | $15.2M |
| 97 | MBX BIOSCIENCES | MBX | 0.14% | 220.06K | $15.1M |
| 98 | ALUMIS | ALMS | 0.14% | 623.93K | $14.9M |
| 99 | ZYMEWORKS | ZYME | 0.13% | 525.71K | $14.4M |
| 100 | SAREPTA THERAPEUTICS | SRPT | 0.13% | 755.00K | $14.3M |
| 101 | AURINIA PHARMACEUTICALS | AUPH | 0.13% | 848.44K | $14.2M |
| 102 | AGIOS PHARMACEUTICALS | AGIO | 0.13% | 415.34K | $14.1M |
| 103 | NOVOCURE | NVCR | 0.13% | 778.19K | $13.7M |
| 104 | BIOHAVEN | BHVN | 0.12% | 934.99K | $13.4M |
| 105 | SUMMIT THERAPEUTICS | SMMT | 0.12% | 1.00M | $13.4M |
| 106 | INTELLIA THERAPEUTICS | NTLA | 0.12% | 985.85K | $13.3M |
| 107 | GRIFOLS ADR REPRESENTING ONE NON-V | GRFS | 0.12% | 1.64M | $13.3M |
| 108 | UROGEN PHARMA | URGN | 0.12% | 286.06K | $13.3M |
| 109 | NUVATION BIO CLASS A | NUVB | 0.12% | 1.85M | $13.1M |
| 110 | FORTREA HOLDINGS INC | FTRE | 0.12% | 702.87K | $12.8M |
| 111 | RECURSION PHARMACEUTICALS CLASS A | RXRX | 0.11% | 3.50M | $12.5M |
| 112 | TREVI THERAPEUTICS | TRVI | 0.11% | 691.18K | $12.4M |
| 113 | STOKE THERAPEUTICS | STOK | 0.11% | 367.53K | $12.3M |
| 114 | TAYSHA GENE THERAPIES | TSHA | 0.11% | 1.98M | $12.3M |
| 115 | COMPASS PATHWAYS ADR PLC | CMPS | 0.11% | 810.90K | $12.1M |
| 116 | SYNDAX PHARMACEUTICALS | SNDX | 0.11% | 600.37K | $12.0M |
| 117 | MINERALYS THERAPEUTICS | MLYS | 0.11% | 452.92K | $11.9M |
| 118 | ANAPTYSBIO | ANAB | 0.11% | 203.22K | $11.9M |
| 119 | IMMUNOCORE HOLDINGS ADR PLC | IMCR | 0.11% | 317.04K | $11.9M |
| 120 | NOVAVAX | NVAX | 0.10% | 1.17M | $11.0M |
| 121 | RAPPORT THERAPEUTICS | RAPP | 0.10% | 213.05K | $10.9M |
| 122 | VIR BIOTECHNOLOGY | VIR | 0.10% | 996.82K | $10.7M |
| 123 | GH RESEARCH PLC | GHRS | 0.10% | 363.27K | $10.5M |
| 124 | INHIBRX BIOSCIENCES INC | INBX | 0.09% | 81.52K | $10.0M |
| 125 | ABSCI CORP | ABSI | 0.09% | 1.00M | $9.6M |
| 126 | ALTO NEUROSCIENCE INC | ANRO | 0.09% | 262.62K | $9.5M |
| 127 | LAKEFRONT BIOTHERAPEUTICS ADR NV | GLPG | 0.08% | 310.44K | $9.2M |
| 128 | MANNKIND | MNKD | 0.08% | 2.21M | $9.2M |
| 129 | REPLIMUNE GROUP | REPL | 0.08% | 574.70K | $9.1M |
| 130 | MESOBLAST ADR REPRESENTING | MESO | 0.08% | 525.53K | $9.0M |
| 131 | TYRA BIOSCIENCES | TYRA | 0.08% | 330.31K | $8.8M |
| 132 | KURA ONCOLOGY | KURA | 0.08% | 645.17K | $8.8M |
| 133 | PRECIGEN | PGEN | 0.08% | 1.17M | $8.5M |
| 134 | SEPTERNA | SEPN | 0.08% | 205.33K | $8.5M |
| 135 | STEVANATO GROUP | STVN | 0.08% | 369.76K | $8.4M |
| 136 | PHARVARIS N V | PHVS | 0.07% | 217.72K | $8.1M |
| 137 | ZENAS BIOPHARMA | ZBIO | 0.07% | 239.05K | $8.1M |
| 138 | JANUX THERAPEUTICS | JANX | 0.07% | 429.86K | $8.0M |
| 139 | PERSONALIS | PSNL | 0.07% | 465.12K | $8.0M |
| 140 | MEIRAGTX HOLDINGS PLC | MGTX | 0.07% | 527.12K | $7.9M |
| 141 | MAZE THERAPEUTICS | MAZE | 0.07% | 258.41K | $7.9M |
| 142 | CASTLE BIOSCIENCES | CSTL | 0.07% | 222.61K | $7.8M |
| 143 | CULLINAN THERAPEUTICS | CGEM | 0.07% | 335.24K | $7.7M |
| 144 | ARRIVENT BIOPHARMA | AVBP | 0.07% | 244.92K | $7.7M |
| 145 | GERON | GERN | 0.07% | 4.72M | $7.3M |
| 146 | MARAVAI LIFESCIENCES HOLDINGS INC | MRVI | 0.07% | 791.67K | $7.1M |
| 147 | BICARA THERAPEUTICS INC | BCAX | 0.06% | 281.67K | $6.9M |
| 148 | CORVUS PHARMACEUTICALS | CRVS | 0.06% | 474.62K | $6.9M |
| 149 | MONTE ROSA THERAPEUTICS | GLUE | 0.06% | 439.73K | $6.4M |
| 150 | ORIC PHARMACEUTICALS | ORIC | 0.06% | 461.12K | $6.4M |
| 151 | RIGEL PHARMACEUTICALS | RIGL | 0.06% | 134.75K | $6.3M |
| 152 | WAVE LIFE SCIENCES INC | WVE | 0.06% | 1.18M | $6.2M |
| 153 | ARBUTUS BIOPHARMA CORP | ABUS | 0.06% | 1.18M | $6.2M |
| 154 | THERAVANCE BIOPHARMA | TBPH | 0.06% | 357.51K | $6.1M |
| 155 | CANDEL THERAPEUTICS INC | CADL | 0.05% | 431.09K | $5.9M |
| 156 | SOLID BIOSCIENCES INC | SLDB | 0.05% | 589.67K | $5.8M |
| 157 | OLEMA PHARMACEUTICALS | OLMA | 0.05% | 523.73K | $5.7M |
| 158 | ANNEXON | ANNX | 0.05% | 1.08M | $5.5M |
| 159 | SANA BIOTECHNOLOGY | SANA | 0.05% | 1.34M | $5.5M |
| 160 | 4D MOLECULAR THERAPEUTICS INC | FDMT | 0.05% | 345.53K | $5.4M |
| 161 | ACLARIS THERAPEUTICS | ACRS | 0.05% | 817.21K | $5.3M |
| 162 | ALVOTECH SA | ALVO | 0.05% | 1.05M | $5.3M |
| 163 | ZEVRA THERAPEUTICS INC | ZVRA | 0.05% | 432.38K | $5.2M |
| 164 | IRONWOOD PHARMA CLASS A | IRWD | 0.05% | 1.17M | $5.1M |
| 165 | NEUROGENE | NGNE | 0.04% | 118.24K | $4.8M |
| 166 | SAGIMET BIOSCIENCES SERIES A | SGMT | 0.04% | 434.06K | $4.5M |
| 167 | SAVARA | SVRA | 0.04% | 790.16K | $4.4M |
| 168 | DESIGN THERAPEUTICS | DSGN | 0.04% | 279.08K | $4.4M |
| 169 | ALTIMMUNE INC | ALT | 0.04% | 1.36M | $4.4M |
| 170 | CYTOMX THERAPEUTICS | CTMX | 0.04% | 1.24M | $4.2M |
| 171 | OPKO HEALTH | OPK | 0.04% | 2.80M | $4.2M |
| 172 | ALLOGENE THERAPEUTICS | ALLO | 0.04% | 1.89M | $4.1M |
| 173 | OMNIAB INC | OABI | 0.04% | 869.67K | $4.1M |
| 174 | CYTEK BIOSCIENCES | CTKB | 0.04% | 875.11K | $4.0M |
| 175 | REGENXBIO | RGNX | 0.04% | 438.81K | $3.9M |
| 176 | ARVINAS INC | ARVN | 0.04% | 402.86K | $3.9M |
| 177 | AURA BIOSCIENCES | AURA | 0.03% | 478.87K | $3.7M |
| 178 | PHATHOM PHARMACEUTICALS | PHAT | 0.03% | 421.57K | $3.7M |
| 179 | CONTINEUM THERAPEUTICS CLASS A | CTNM | 0.03% | 215.48K | $3.7M |
| 180 | AUTOLUS THERAPEUTICS ADR PLC | AUTL | 0.03% | 1.50M | $3.7M |
| 181 | USD CASH | — | 0.03% | 3.61M | $3.6M |
| 182 | EDITAS MEDICINE | EDIT | 0.03% | 1.05M | $3.5M |
| 183 | CABALETTA BIO | CABA | 0.03% | 1.06M | $3.4M |
| 184 | PACIFIC BIOSCIENCES OF CALIFORNIA | PACB | 0.03% | 2.16M | $3.3M |
| 185 | PROTHENA PLC | PRTA | 0.03% | 346.13K | $3.3M |
| 186 | C4 THERAPEUTICS | CCCC | 0.03% | 742.95K | $3.1M |
| 187 | BRIDGEBIO ONCOLOGY THERAPEUTICS IN | BBOT | 0.03% | 321.38K | $3.0M |
| 188 | ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | 0.03% | 192.97K | $3.0M |
| 189 | ROCKET PHARMACEUTICALS | RCKT | 0.03% | 767.07K | $2.9M |
| 190 | ENANTA PHARMACEUTICALS INC | ENTA | 0.03% | 204.49K | $2.9M |
| 191 | GINKGO BIOWORKS HOLDINGS CLASS A | DNA | 0.03% | 374.13K | $2.8M |
| 192 | FULGENT GENETICS | FLGT | 0.02% | 135.40K | $2.7M |
| 193 | SILENCE THERAPEUTICS ADR REPRESENT | SLN | 0.02% | 195.09K | $2.7M |
| 194 | ARS PHARMACEUTICALS | SPRY | 0.02% | 464.29K | $2.7M |
| 195 | TECTONIC THERAPEUTIC | TECX | 0.02% | 69.91K | $2.6M |
| 196 | PRIME MEDICINE | PRME | 0.02% | 703.67K | $2.6M |
| 197 | ATEA PHARMACEUTICALS | AVIR | 0.02% | 479.86K | $2.6M |
| 198 | KYVERNA THERAPEUTICS | KYTX | 0.02% | 279.56K | $2.5M |
| 199 | BIOAGE LABS | BIOA | 0.02% | 234.58K | $2.4M |
| 200 | ANAVEX LIFE SCIENCES CORP | AVXL | 0.02% | 663.48K | $2.4M |
| 201 | LEXEO THERAPEUTICS | LXEO | 0.02% | 456.89K | $2.3M |
| 202 | VANDA PHARMACEUTICALS INC | VNDA | 0.02% | 422.72K | $2.3M |
| 203 | IMMUNEERING CLASS A | IMRX | 0.02% | 426.67K | $2.2M |
| 204 | PERSPECTIVE THERAPEUTICS INC | CATX | 0.02% | 668.21K | $2.2M |
| 205 | MYRIAD GENETICS | MYGN | 0.02% | 655.21K | $2.1M |
| 206 | EMERGENT BIOSOLUTIONS | EBS | 0.02% | 360.80K | $2.0M |
| 207 | UPSTREAM BIO | UPB | 0.02% | 268.99K | $1.9M |
| 208 | STANDARD BIOTOOLS | LAB | 0.02% | 2.78M | $1.8M |
| 209 | LARIMAR THERAPEUTICS | LRMR | 0.01% | 389.14K | $1.6M |
| 210 | FULCRUM THERAPEUTICS | FULC | 0.01% | 418.04K | $1.6M |
| 211 | PEPGEN | PEPG | 0.01% | 471.03K | $1.6M |
| 212 | FOGHORN THERAPEUTICS | FHTX | 0.01% | 232.93K | $1.6M |
| 213 | KEROS THERAPEUTICS | KROS | 0.01% | 134.94K | $1.6M |
| 214 | LINEAGE CELL THERAPEUTICS INC | LCTX | 0.01% | 1.39M | $1.6M |
| 215 | BLK CSH FND TREASURY SL AGENCY | — | 0.01% | 1.54M | $1.5M |
| 216 | AC IMMUNE SA | ACIU | 0.01% | 454.61K | $1.3M |
| 217 | HUMACYTE INC | HUMA | 0.01% | 1.82M | $1.3M |
| 218 | VOYAGER THERAPEUTICS | VYGR | 0.01% | 365.88K | $1.3M |
| 219 | SIONNA THERAPEUTICS | SION | 0.01% | 197.08K | $1.2M |
| 220 | BICYCLE THERAPEUTICS ADR PLC | BCYC | 0.01% | 277.24K | $1.2M |
| 221 | ENTRADA THERAPEUTICS | TRDA | 0.01% | 158.46K | $1.2M |
| 222 | PYXIS ONCOLOGY INC | PYXS | 0.01% | 393.50K | $1.2M |
| 223 | NOVABRIDGE BIOSCIENCES ADR | IMAB | 0.01% | 621.09K | $1.2M |
| 224 | CARIBOU BIOSCIENCES | CRBU | 0.01% | 660.18K | $1.2M |
| 225 | TENAYA THERAPEUTICS | TNYA | 0.01% | 1.57M | $1.1M |
| 226 | QUANTUM SI INC CLASS A | QSI | 0.01% | 1.26M | $1.1M |
| 227 | CODEXIS | CDXS | 0.01% | 623.47K | $1.0M |
| 228 | LENZ THERAPEUTICS | LENZ | 0.01% | 202.71K | $946.7K |
| 229 | LYELL IMMUNOPHARMA | LYEL | 0.01% | 56.81K | $879.9K |
| 230 | NEUMORA THERAPEUTICS INC | NMRA | 0.01% | 570.88K | $856.3K |
| 231 | QUANTERIX | QTRX | 0.01% | 294.50K | $821.7K |
| 232 | BLACK DIAMOND THERAPEUTICS INC | BDTX | 0.01% | 364.54K | $816.6K |
| 233 | CELLECTIS ADR REPRESENTING SA | CLLS | 0.01% | 234.30K | $803.6K |
| 234 | ADC THERAPEUTICS SA | ADCT | 0.01% | 702.54K | $730.6K |
| 235 | GOSSAMER BIO | GOSS | 0.01% | 3.34M | $682.3K |
| 236 | AARDVARK THERAPEUTICS | AARD | 0.01% | 93.59K | $678.5K |
| 237 | ALPHA TEKNOVA | TKNO | 0.01% | 81.05K | $604.7K |
| 238 | JYONG BIOTECH LTD | MENS | 0.00% | 215.53K | $480.6K |
| 239 | CASH COLLATERAL USD SGAFT | — | 0.00% | 384.00K | $384.0K |
| 240 | AKERO THERAPEUTICS CVR | — | 0.00% | 515.95K | $335.4K |
| 241 | IMMUTEP ADS REPRESENTING LTD | IMMP | 0.00% | 770.31K | $300.1K |
| 242 | CHINOOK THERAPEUTICS INC | — | 0.00% | 320.96K | $54.6K |
| 243 | ARCELLX INC CVR | — | 0.00% | 335.81K | $23.5K |
| 244 | CARTESIAN THERAPEUTICS INC | — | 0.00% | 7.50K | $1.9K |
| 245 | FUSION PHARMACEUTICALS INC CVR | — | 0.00% | 1.88K | $1.0K |
| 246 | CARGO THERAPEUTICS INC | — | 0.00% | 198.10K | $1.98 |
| 247 | THIRD HARMONIC BIO INC | THRD | 0.00% | 134.48K | $1.34 |
| 248 | AKOUOS CVRS Prvt | — | 0.00% | 157.09K | $1.57 |
| 249 | OMNIAB INC $15.00 VESTING Prvt | — | 0.00% | 46.84K | $0.47 |
| 250 | OMNIAB INC $12.50 VESTING Prvt | — | 0.00% | 46.84K | $0.47 |
Clique em um ticker para ver todos os ETFs que o detêm.
Exposição Setorial
Exposição Geográfica
Ponderações por país conforme reportadas pelo fornecedor de dados. As classificações desenvolvido/emergente/fronteira seguem a metodologia descrita na página de Metodologia. Com cobertura cambial: Nenhuma cobertura de risco indicada no nome do fundo.
Distribuições
| Yield (TTM) | 0.19% | Pago (últimos 12 meses) | $0.4115 |
| Frequência | Quarterly | SEC yield | Não fornecido pela nossa fonte de dados — consulte a página do emissor |
| Último ex-dividendo | Jun 15, 2026 | Último pagamento | $0.0238 (Jun 18, 2026) |
| Crescimento 1A | +7.17% | Crescimento 3A / 5A (a.a.) | +7.55% / +7.83% |
| Data ex-dividendo | Data de Registro | Data de pagamento | Valor |
|---|---|---|---|
| Jun 15, 2026 | Jun 15, 2026 | Jun 18, 2026 | $0.0238 |
| Mar 17, 2026 | Mar 17, 2026 | Mar 20, 2026 | $0.1218 |
| Dec 16, 2025 | Dec 16, 2025 | Dec 19, 2025 | $0.1831 |
| Sep 16, 2025 | Sep 16, 2025 | Sep 19, 2025 | $0.0828 |
| Mar 18, 2025 | Mar 18, 2025 | Mar 21, 2025 | $0.1212 |
| Dec 17, 2024 | Dec 17, 2024 | Dec 20, 2024 | $0.0624 |
| Sep 25, 2024 | Sep 25, 2024 | Sep 30, 2024 | $0.2005 |
| Mar 21, 2024 | Mar 22, 2024 | Mar 27, 2024 | $0.1260 |
| Dec 20, 2023 | Dec 21, 2023 | Dec 27, 2023 | $0.1240 |
| Sep 26, 2023 | Sep 27, 2023 | Oct 02, 2023 | $0.1532 |
| Jun 07, 2023 | Jun 08, 2023 | Jun 13, 2023 | $0.0062 |
| Mar 23, 2023 | Mar 24, 2023 | Mar 29, 2023 | $0.0646 |
Yield de distribuição acumulado = últimos 12 meses de caixa distribuído ÷ preço atual. NÃO é o yield SEC de 30 dias e a continuidade das distribuições não é garantida. A diferença explicada →
Estatísticas de Risco
| Volatilidade 1A / 3A | 21.65% / 20.92% | Sharpe 1A / 3A | 2.59 / 0.88 |
| Drawdown máximo 1A / 3A | -9.63% / -24.85% | Sortino 1A | 4.30 |
| Beta vs S&P 500 (3A) | 0.8 | Correlação com o S&P 500 (1A) | 0.437 |
| Desvio negativo 1A | 13.05% | Taxa livre de risco utilizada | 3.71% (3M T-bill, FRED) |
Calculado por ETF Explorer com base em fechos diários ajustados de dividendos; a volatilidade e o drawdown são valores anualizados/do período; a exposição ao S&P 500 é representada pelo SPY. Em Aug 27, 2026. Fórmulas →
Liquidez
| Volume hoje | 1.39M | Volume médio | 1.55M |
| AUM | $10.84B | Prêmio/Desconto | -0.53% |
| Spread bid/ask | Não fornecido pela nossa fonte de dados. Verifique a tela de cotações do seu corretora; os spreads são mais amplos na abertura e no fechamento do mercado. | ||
O prêmio/desconto compara o preço de mercado defasado com o último NAV divulgado — trata-se de um valor indicativo, não do prêmio/desconto oficial de fechamento. Como funciona a liquidez dos ETFs →
Fluxos de Fundos (estimados)
| Período | Fluxo líquido est. | % do AUM inicial | AUM início → fim |
|---|---|---|---|
| 1 Dia | $0.00 | 0.00% | $10.84B → $10.84B |
| 1 Semana | $471.3M | +4.64% | $10.16B → $10.84B |
Estimativa do ETF Explorer: variação do AUM reportado menos o efeito do movimento de mercado, a partir dos nossos próprios snapshots diários. Não são dados oficiais de criação/resgate da emissora.
Recursos Oficiais do Fundo
Página Oficial do Fundo ↗
Site da Emissora do ETF (iShares) ↗
Registros de prospecto (SEC EDGAR) ↗
Relatórios anuais / semestrais (SEC EDGAR) ↗
Todos os arquivos na SEC ↗
Links externos abrem o site da emissora ou o SEC EDGAR em uma nova aba. O prospecto e os documentos oficiais são sempre a fonte autoritativa — consulte-os antes de investir.
Últimas Notícias sobre IBB
Nenhum artigo menciona este fundo diretamente nos últimos 7 dias — exibindo cobertura geral de ETFs.
Stock Market: Will S&P 500 Open Up or Down Today? ↗
U.S. stock futures are trending higher early Thursday as Wall Street processes Nvidia Corp.‘s (NASDAQ:NVDA) highly anticipated earnings, strong…
Benzinga · Aug 27, 02:45 UTC
More Sudanese oil available for marine fuel blending as China demand eases ↗
More barrels of South Sudan's Dar Blend crude oil returned to the marine fuel blending pool in Singapore and Malaysia this month as demand from…
Reuters · Aug 27, 01:30 UTC
Gold (XAU/USD) & Silver Price Forecast: Sticky PCE Puts Warsh and Fed in Focus ↗
Gold and silver remain balanced as sticky PCE revives Fed tightening risk, while Warsh, Middle East tensions and fiscal concerns support volatility.
FXEmpire · Aug 27, 01:14 UTC
Natural Gas and Oil Forecast: Diesel Stocks Tighten as Hormuz Flows Slowly Recover ↗
Hormuz talks ease some oil supply fears, but tight diesel stocks keep fuel markets constrained as WTI and Brent remain technically vulnerable.
FXEmpire · Aug 27, 01:09 UTC
Kospi Index on edge as SK Hynix stock jumps after strong Nvidia guidance ↗
The Kospi Index wavered on Thursday after the Bank of Korea (BoK) delivered a second interest rates hike as it battles with the relatively elevated…
Invezz · Aug 27, 00:22 UTC
Gold Rises as Dollar Debasement Trade Attracts Investors ↗
Gold rose in Asian trade. The precious metal faces limited downside due to the so-called dollar debasement trade continuing to attract investor…
WSJ · Aug 26, 23:45 UTC
Todas as notícias de IBB →
Ajuda guiada: AUM é o tamanho do fundo. O expense ratio é o custo anual embutido nos retornos. O NAV é o valor dos ativos do fundo por cota; o preço de mercado pode ficar ligeiramente acima (prêmio) ou abaixo (desconto) dele. O retorno total pressupõe que as distribuições foram reinvestidas. Cada conjunto de dados exibe sua própria data de referência, pois carteiras, ativos e cotações são atualizados em cronogramas diferentes.